Cargando…
P-031: TRANSITION FROM LONG TERM HIGH DOSE FULL AGONIST OPIOIDS TO BUPRENORPHINE IN THE INPATIENT SETTING FOR PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE: A MODIFIED INDIVIDUALIZED MICRO INDUCTION APPROACH. A SINGLE CENTER EXPERIENCE
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426804/ http://dx.doi.org/10.1097/01.HS9.0000873020.74348.64 |
| _version_ | 1784778760215592960 |
|---|---|
| author | E., SAAH R., PITTS T., NEW J., STERNER-ALLISON H., GIANNOPOULOS B., GEE |
| author_facet | E., SAAH R., PITTS T., NEW J., STERNER-ALLISON H., GIANNOPOULOS B., GEE |
| author_sort | E., SAAH |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9426804 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94268042022-08-31 P-031: TRANSITION FROM LONG TERM HIGH DOSE FULL AGONIST OPIOIDS TO BUPRENORPHINE IN THE INPATIENT SETTING FOR PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE: A MODIFIED INDIVIDUALIZED MICRO INDUCTION APPROACH. A SINGLE CENTER EXPERIENCE E., SAAH R., PITTS T., NEW J., STERNER-ALLISON H., GIANNOPOULOS B., GEE Hemasphere Poster Presentations Lippincott Williams & Wilkins 2022-08-16 /pmc/articles/PMC9426804/ http://dx.doi.org/10.1097/01.HS9.0000873020.74348.64 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Poster Presentations E., SAAH R., PITTS T., NEW J., STERNER-ALLISON H., GIANNOPOULOS B., GEE P-031: TRANSITION FROM LONG TERM HIGH DOSE FULL AGONIST OPIOIDS TO BUPRENORPHINE IN THE INPATIENT SETTING FOR PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE: A MODIFIED INDIVIDUALIZED MICRO INDUCTION APPROACH. A SINGLE CENTER EXPERIENCE |
| title | P-031: TRANSITION FROM LONG TERM HIGH DOSE FULL AGONIST OPIOIDS TO BUPRENORPHINE IN THE INPATIENT SETTING FOR PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE: A MODIFIED INDIVIDUALIZED MICRO INDUCTION APPROACH. A SINGLE CENTER EXPERIENCE |
| title_full | P-031: TRANSITION FROM LONG TERM HIGH DOSE FULL AGONIST OPIOIDS TO BUPRENORPHINE IN THE INPATIENT SETTING FOR PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE: A MODIFIED INDIVIDUALIZED MICRO INDUCTION APPROACH. A SINGLE CENTER EXPERIENCE |
| title_fullStr | P-031: TRANSITION FROM LONG TERM HIGH DOSE FULL AGONIST OPIOIDS TO BUPRENORPHINE IN THE INPATIENT SETTING FOR PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE: A MODIFIED INDIVIDUALIZED MICRO INDUCTION APPROACH. A SINGLE CENTER EXPERIENCE |
| title_full_unstemmed | P-031: TRANSITION FROM LONG TERM HIGH DOSE FULL AGONIST OPIOIDS TO BUPRENORPHINE IN THE INPATIENT SETTING FOR PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE: A MODIFIED INDIVIDUALIZED MICRO INDUCTION APPROACH. A SINGLE CENTER EXPERIENCE |
| title_short | P-031: TRANSITION FROM LONG TERM HIGH DOSE FULL AGONIST OPIOIDS TO BUPRENORPHINE IN THE INPATIENT SETTING FOR PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE: A MODIFIED INDIVIDUALIZED MICRO INDUCTION APPROACH. A SINGLE CENTER EXPERIENCE |
| title_sort | p-031: transition from long term high dose full agonist opioids to buprenorphine in the inpatient setting for pediatric patients with sickle cell disease: a modified individualized micro induction approach. a single center experience |
| topic | Poster Presentations |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426804/ http://dx.doi.org/10.1097/01.HS9.0000873020.74348.64 |
| work_keys_str_mv | AT esaah p031transitionfromlongtermhighdosefullagonistopioidstobuprenorphineintheinpatientsettingforpediatricpatientswithsicklecelldiseaseamodifiedindividualizedmicroinductionapproachasinglecenterexperience AT rpitts p031transitionfromlongtermhighdosefullagonistopioidstobuprenorphineintheinpatientsettingforpediatricpatientswithsicklecelldiseaseamodifiedindividualizedmicroinductionapproachasinglecenterexperience AT tnew p031transitionfromlongtermhighdosefullagonistopioidstobuprenorphineintheinpatientsettingforpediatricpatientswithsicklecelldiseaseamodifiedindividualizedmicroinductionapproachasinglecenterexperience AT jsternerallison p031transitionfromlongtermhighdosefullagonistopioidstobuprenorphineintheinpatientsettingforpediatricpatientswithsicklecelldiseaseamodifiedindividualizedmicroinductionapproachasinglecenterexperience AT hgiannopoulos p031transitionfromlongtermhighdosefullagonistopioidstobuprenorphineintheinpatientsettingforpediatricpatientswithsicklecelldiseaseamodifiedindividualizedmicroinductionapproachasinglecenterexperience AT bgee p031transitionfromlongtermhighdosefullagonistopioidstobuprenorphineintheinpatientsettingforpediatricpatientswithsicklecelldiseaseamodifiedindividualizedmicroinductionapproachasinglecenterexperience |